May 28, 2012

Sanofi Inaugurates Lantus® SoloSTAR® Pen Assembly Plant in its Beijing Facility

- The Group Pledges Continuous Commitment to Diabetes Management in China -

 

Sanofi Inaugurates Lantus® SoloSTAR® Pen Assembly Plant in its Beijing Facility
- The Group Pledges Continuous Commitment to Diabetes Management in China -

Paris, France, May 28, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the inauguration of a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus® SoloSTAR® at its Beijing plant located at the Beijing Economic-Technological Development Area (BDA). Presiding over the inauguration ceremony, Christopher A. Viehbacher, Chief Executive Officer of Sanofi, announced the second phase of the US$90 million project to install a high-tech cartridge aseptic production line. With a designed capacity of 48 million units per year, the facility is expected to help fulfil the needs of people with diabetes and ultimately improve the standard of diabetes care in China.